Why Diabetic Patients Quietly Stop Taking Their Medicine — And How a Phone Call Fixes It

Ask a patient in clinic whether they're taking their metformin, and almost everyone says yes. It's not usually a lie — it's optimism, or embarrassment, or genuinely not remembering that they skipped four doses last week. Diabetes non-adherence is one of the least confrontational forms of non-adherence there is: nobody stops dramatically, they just drift, one skipped refill at a time, until an HbA1c three months later tells the real story.

By then, the drift has usually cost something — a slow climb in fasting sugars, early neuropathy symptoms the patient assumed were unrelated, or a foot complication that started as something a two-week-earlier phone call could have caught.

Where adherence actually breaks

• The refill gap — a patient runs out on a Friday, tells themselves they'll get to the pharmacy over the weekend, and by the time they do it's been eight days off medication.
• Insulin timing drift — doses get pushed later and later around a changing work schedule until they're barely aligned with meals anymore.
• Silent side effects — GI discomfort from metformin that a patient just tolerates, or quietly stops the drug over, without ever mentioning it because "it wasn't serious enough to call about."
• Foot checks that never happen — the single most preventable driver of diabetic amputation, and the easiest thing to forget between visits.

What a recurring check-in call is actually for

None of the four items above show up reliably in a quarterly visit, because a quarterly visit is a snapshot and adherence is a pattern that lives in the weeks between snapshots. What changes the picture is a short, recurring call — not a lecture, four or five specific questions: did you get the refill, are you taking it at the same time each day, any new numbness or tingling, when did you last check your feet.

Adherence isn't a single decision a patient makes once. It's dozens of small decisions a week, most of which nobody is watching — until someone asks, consistently, on a schedule.

Running that call by hand for a full diabetes panel isn't realistic for any clinic I know of — not because the questions are hard, but because there are simply too many patients and too few hours. What we've moved to instead is a structured, recurring call — every two to three weeks depending on how recently a patient's regimen changed — that asks exactly those questions, logs the answers against the patient's record, and flags anything concerning straight to our team rather than waiting for it to surface at the next visit.

The part that surprised me

I expected the calls to mostly catch missed refills. What they've actually surfaced more of is the quiet side-effect non-adherence — patients who stopped a drug on their own weeks ago because of GI symptoms they didn't think were worth a clinic visit over. Catching that in week two instead of at the three-month mark means a simple dose adjustment instead of three months of uncontrolled sugars we'd otherwise attribute to "poor compliance" without ever finding out why.

The technology isn't the interesting part. The interesting part is that someone finally asks, every single time, instead of only when a patient remembers to bring it up.